Posts in tag

liver health


As the COVID-19 crisis in NSW continues, there’s been plenty happening in the pharmacy sector this week More and more pharmacies were added to the list of COVID-19 exposure sites …

A supplier of unapproved sports supplements has been told to pay $11 million, as the TGA points out their potential to damage health The Federal Court of Australia has ordered …

Debbie Rigby takes a look at the latest in research news Inhaled budesonide in the treatment of early COVID-19 (STOIC) A randomised controlled trial (Steroids in COVID-19; STOIC) of inhaled …

The TGA is investigating the safety of Valerian following a small number of reports of liver injury Noting common uses for Valeriana officinalis – such as to help manage nervousness, …

With many of Australia’s pharmacists descending on Sydney to attend the PSA19 conference, it’s been a very busy week in the world of pharmacy… At the conference, Health Minister Greg …

What impact can pharmacists have on the uptake of DAAs? asks Carlene McMaugh Hepatitis C is now in a unique category of conditions where we have a medication that can …

Direct-acting antivirals are associated with reduced risk of mortality and liver cancer, according to results from the first prospective, longitudinal study investigating their use in treating chronic hepatitis C The …

Deaths from hepatitis C have dropped by a fifth, highlighting the importance of new treatments and their affordability New Kirby Institute data presented at the Australasian Viral Hepatitis Conference in …

The number of Australians receiving breakthrough antiviral therapy to cure hepatitis C has sharply declined This has prompted appeals for more Australians living with the virus to come forward to …

Guild Learning and Development is partnering with Gilead Sciences in an online course The course is titled Management of Hepatitis C and the role of pharmacy. Hepatitis C (HCV), a …

Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, …

People treated with new direct acting antivirals feel old and new hepatitis C treatments are “like chalk and cheese” On World Hepatitis Day today (28 July), Hepatitis NSW is promoting …